Luciano José Megale Costa

69PUBLICATIONS
178CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNuclear physicsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|Jul 29, 2026
De-escalation trials in multiple myeloma: past, present and future.

|Jul 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

|Jul 22, 2026
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.

|Jul 20, 2026
Redefining functional high-risk multiple myeloma in the context of upfront quadruplet therapy and autologous stem cell transplantation.

|Jun 03, 2026
Targeting BCMA in patients with relapsed/refractory multiple myeloma in 1 to 3 prior lines of therapy.

|Jun 03, 2026
Arlocabtagene autoleucel: a GPRC5D-targeted CAR T-cell therapy for heavily pretreated relapsed/refractory multiple myeloma.

Pageof 12

Frequent Collaborators

11 joint publications

Susan Bal

10 joint publications

Maria-Victoria Mateos

10 joint publications

Binod Dhakal

8 joint publications

Smith Giri